Serina Therapeutics, Inc. Q2 FY2020 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2020 Q2 Call date: 2020-08-14 Concluded

Quarter scorecard

Revenue

$45,000

-88.2% YoY

Gross margin

93.3%

+7.2 pp YoY

Net income

Grant Revenues $36,000

Other Revenues $9,000